CARLOS SALAS: Open Payments
NPI 1144845249 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,959 in 94 payments from 35 companies in 2025. Trend: 2023 $2,980 · 2024 $1,392 · 2025 $2,959
Food & beverage: $2,560Education: $399
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 15 | $324 |
| Incyte Corporation | 4 | $235 |
| Karyopharm Therapeutics Inc. | 7 | $230 |
| Janssen Biotech, Inc. | 5 | $159 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Medtronic, Inc. | 1 | $130 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Exelixis Inc. | 2 | $124 |
Products named: Enhertu, XPOVIO, MONJUVI, DATROWAY, OSTEOCOOL RF ABLATION SYSTEM, MONOFERRIC, OTEZLA, Vonjo.
Industry payments across TX — which companies pay providers there.
